UNSPSC 51192312: Chromic sulfate/cupric sulfate/manganese sulfate/zinc sulfate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN490. This VA Drug Class (TN490) classifies this compound as belonging to the group ELECTROLYTES/MINERALS, COMBINATIONS.

UNSPSC 51192312 Chromic sulfate/cupric sulfate/manganese sulfate/zinc sulfate is a Commodity code covering chemical treatment products for municipal water and wastewater systems. State and local governments procure under this code primarily for water pollution control facilities, wastewater treatment operations, and compliance-driven infrastructure — though recent solicitation activity shows broader chemical supply usage spanning valve components, parenteral pharmacy products, and water treatment chemicals. Issuing bodies include municipal water departments (City of Meriden, Connecticut), county environmental and public works divisions (Broward County, Florida), and state correctional departments (Washington State Department of Corrections). The actual purchasing mix reveals a fragmented scope: municipal water treatment chemicals like sodium bisulfite dominate the concrete RFQ activity, while state corrections procurement under this code spans parenteral nutrition solutions and intravenous products for incarcerated healthcare, and county infrastructure procurement includes specialized valve components for wastewater system compliance.

Recent solicitation activity spans three states. The City of Meriden posted an IFB for sodium bisulfite chemical supply (B027-15, due July 29, 2026) for its Water Pollution Control Facility. Broward County, Florida issued an RFI (BLD6232026F23, due September 29, 2026) on DeZurik/APCO valves, parts, and repair services for wastewater treatment compliance, seeking to determine if alternatives to the current exclusive provider exist and whether vendors could support SCADA-equipped valve systems for remote monitoring. The Washington State Department of Corrections released an RFQ (RFQQK13020, due October 7, 2026) for parenteral products and services — including total parenteral nutrition, intravenous solutions, and controlled substances — to eight correctional facilities across three regions, with a pre-bid conference scheduled for September 23, 2026 and aspirational small-business (25%), minority-owned (10%), women-owned (6%), and veteran-owned (5%) goals. The code shows dispersed geographic activity across the Southeast, Mid-Atlantic, and Pacific Northwest, with recent procurement focused on chemical supply fundamentals alongside specialized medical and infrastructure applications.